We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recent insight into critical concerns in international quality regulations governing the pharmaceutical industry: A Review.
- Authors
ABOUHUSSEIN, DALIA M. N.; SABRY, PETER; MOGHAWRY, HEND M.
- Abstract
The Pharmaceutical industry is an essential trade that involves critical processes which have a direct impact on human health. Manufacturers should build in quality within each stage by applying the national &/or international quality guidelines related to this aspect. Since World Health Organization (WHO) is concerned with all matters that affect the human health, subsequently it issued several international guidelines and technical reports to support and warrant the quality of each step of this vital industry all around the world. So, our purpose is to highlight the critical concerns in the latest updated good practices to ensure the quality of the manufactured pharmaceutical products. WHO guidelines and annexes were searched. Relevant guidelines that administer the least requirements and the recommendations from the very beginning of the predevelopment stage by desk research in the laboratory until the pharmaceutical product is distributed in the market. WHO updates their guidelines or issues a new one whenever a certain observation or feedback is repeatedly noticed that may be thought to be critical to human health or may lead to an unreliable decision. However, it is recommended to set up a review date for each guideline to ensure its efficiency and suitability of use.
- Publication
International Journal of Pharmaceutical Research (09752366), 2019, Vol 11, Issue 1, p708
- ISSN
0975-2366
- Publication type
Academic Journal
- DOI
10.31838/ijpr/2019.11.01.306